French tech company develops cutting-edge self-stabilizing exoskeletons to enable walking for people with mobility impairments due to stroke, spinal cord injuries or motor neuron diseases

法国科技公司开发出尖端的自我稳定外骨骼，使中风、脊髓损伤或运动神经元疾病导致的行动障碍患者能够行走

Cure's 22 resident companies share mission to foster collaborations spanning disciplines, sectors and geographies to advance health

Cure的22家常驻公司共同致力于促进跨学科、部门和地理区域的合作，以促进健康

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Wandercraft, developer of the world's first in market self-stabilizing exoskeleton designed to enable people with walking impairments to stand and walk again, announced today the opening of its U.S. headquarters at Cure®, a healthcare innovation campus in New York City.

2023年12月12日，纽约/PRNewswire/--Wandercraft公司今天宣布，其美国总部在纽约市的医疗创新园区Cure®开业。Wandercraft公司是世界上第一个上市的自我稳定外骨骼的开发商，该外骨骼旨在使有行走障碍的人能够再次站立和行走。

The Company now has headquarters both in the U.S. where its CEO Matthieu Masselin has relocated, and in France where it originated, after receiving clearance from the U.S. Food and Drug Administration in early 2023 for its lead product, the hands-free Atalante X™ exoskeleton, for use in stroke rehabilitation..

该公司目前的总部位于首席执行官马蒂厄·马塞林（MatthieuMasselin）迁址的美国，以及在2023年初获得美国食品和药物管理局（FDA）批准其主要产品免提阿塔兰特X（Atalante X）后成立的法国™外骨骼，用于中风康复。。

'Wandercraft's new experiential space at Cure immerses us in the heart of the world's largest healthcare market and moves us closer to achieving our goal of creating new standards of care, recovery and movement for patients with severe mobility issues due to injury or illness,' said Matthieu Masselin, CEO of Wandercraft.

Wandercraft首席执行官马蒂厄·马塞林（MatthieuMasselin）说：“Wandercraft在Cure的新体验空间使我们沉浸在世界最大医疗保健市场的中心，并使我们更接近实现为因受伤或疾病导致严重行动不便的患者创造新的护理、康复和运动标准的目标。”。

'Cure enhances our ability to collaborate with leading research institutions and other cutting-edge entrepreneurs, while applying our strong clinical and engineering expertise to create state-of-the-art robotic exoskeleton technologies that improve patients' clinical and functional outcomes.'.

“Cure增强了我们与领先研究机构和其他尖端企业家合作的能力，同时应用我们强大的临床和工程专业知识来创建最先进的机器人外骨骼技术，以改善患者的临床和功能结果。”。

Wandercraft will host an invite-only Keynote event at 11 a.m. ET on Wednesday, Dec. 13 at Cure, 345 Park Avenue South, New York City. The event will include demonstrations of its new Personal Exoskeleton that will offer new, revolutionary options to those of us in wheelchairs.

Wandercraft将于美国东部时间12月13日星期三上午11点在纽约市公园大道南345号Cure举办一场仅限邀请的主题演讲活动。该活动将包括展示其新的个人外骨骼，这将为我们这些坐轮椅的人提供新的革命性选择。

'Wandercraft's technology, which masterfully combines its expertise in biomechanics engineering and neurobiology, exemplifies the innovative approaches that Cure residents are bringing to the healthcare ecosystem,' said Seema Kumar, CEO of Cure. 'By joining our community, Wandercraft also furthers Cure's mission to convene healthcare innovators and foster meaningful collaborations among organizations that span disciplines, sectors and geographies.'.

Cure首席执行官西玛·库马尔（SeemaKumar）说：“Wandercraft的技术巧妙地结合了其在生物力学工程和神经生物学方面的专业知识，体现了治愈居民为医疗保健生态系统带来的创新方法。”通过加入我们的社区，Wandercraft还进一步推动了Cure的使命，即召集医疗保健创新者，并促进跨学科，跨部门和跨地域的组织之间有意义的合作。”。

Wandercraft is joining Cure's group of start-up and established companies that have collectively raised more than $760 million since 2021. The campus community offers residents opportunities to create synergies and collaborative partnerships with peer organizations that span medical technology, healthcare services, therapeutics, healthcare investment, academic research and non-profit initiatives.

Wandercraft加入了Cure的初创和成熟公司集团，自2021年以来，这些公司共筹集了7.6亿美元。校园社区为居民提供了与医疗技术、医疗保健服务、治疗、医疗保健投资、学术研究和非营利性倡议等同行组织建立协同增效和合作伙伴关系的机会。

Cure offers additional networking and employee education opportunities focused on critical health topics through its industry-leading event programming..

Cure通过其业界领先的活动编程，提供了更多关注关键健康主题的社交和员工教育机会。。

The Need for Walking RoboticsGlobally, about 18 to 23 million people live with a spinal cord injury (SCI), due to an accident or illness, that impairs, or has potential to damage, their mobility.i SCIs also may increase patients' risks for developing secondary medical conditions such as pressure ulcers, pain, muscle spasms, deep vein thrombosis, respiratory illnesses or chronic pain.ii In the United States, 255,000 to 383,000 people live with traumatic SCIiii, and SCI can occur in the more than 795,000 people who experience a strokeiv and the nearly 1 million people who live with multiple sclerosis each year.v.

对步行机器人的需求全球约有1800万至2300万人因意外或疾病而患有脊髓损伤（SCI），这会损害或有可能损害他们的活动能力。SCI还可能增加患者发生继发性疾病的风险，例如压疮，疼痛，肌肉痉挛，深静脉血栓形成，呼吸系统疾病或慢性疼痛。在美国，255000至383000人患有创伤性SCIII，每年有795000多人患有中风，近100万人患有多发性硬化症。

Wandercraft developed Atalante X with a proprietary self-balancing feature that enables patients to move in multiple directions without using their hands or an assistive device. Atalante X includes a dynamic Active Balance mode, unavailable elsewhere in the exoskeleton market, that leverages a motion sensor on the patient's back to enable the exoskeleton to follow the patient's movements.

Wandercraft开发的Atalante X具有专有的自我平衡功能，使患者无需使用手或辅助设备即可向多个方向移动。Atalante X包括一种动态主动平衡模式，该模式在外骨骼市场的其他地方不可用，它利用患者背部的运动传感器使外骨骼能够跟随患者的运动。

Active Balance brings more freedom to the patient's rehabilitation program, including gamification of the sessions to keep the patients engaged and work on core strength and balance as well as gait. Atalante also is battery powered and has an adjustable gait..

主动平衡为患者的康复计划带来了更多自由，包括游戏化疗程，以保持患者的参与，并致力于核心力量和平衡以及步态。Atalante也由电池供电，步态可调。。

Atalante X received a Conformité Européene (CE) Mark in 2019 because it complies with the European Union's New Approach Directives, part of the mandatory conformity marking EU uses to regulate goods sold within the European Economic Area. It was cleared by the FDA in the Stroke indication in December 2022.

Atalante X于2019年获得了ConformitéEuropeéene（CE）标志，因为它符合欧盟的新方法指令，这是欧盟用于监管欧洲经济区内销售货物的强制性符合性标志的一部分。2022年12月，FDA在中风适应症中予以批准。

Since 2019, more than 2,000 patients with a variety of medical conditions have used Atalante X as part of their treatment at multiple European rehabilitation hospitals, tallying almost 10,000 sessions in 2023 alone..

自2019年以来，2000多名患有各种疾病的患者在多家欧洲康复医院使用Atalante X作为治疗的一部分，仅2023年就有近10000次治疗。。

ABOUT WANDERCRAFTFounded in 2012, Wandercraft is a French company, a pioneer of realistic and autonomous walking exoskeletons. The team has a lead of several years in dynamic walking algorithms, artificial intelligence and technologies related to walking robotics. The development of a personal exoskeleton is also underway with the aim, within a few years, of improving the mobility of millions of people with reduced mobility, at home and in their daily lives.

关于Wandercraft成立于2012年，Wandercraft是一家法国公司，是逼真和自主行走外骨骼的先驱。该团队在动态步行算法、人工智能和步行机器人相关技术方面领先多年。个人外骨骼的开发也正在进行中，目的是在几年内改善数百万流动性降低的人在家中和日常生活中的流动性。

Wandercraft distributes its exoskeletons to health institutions and is developing a personal version. It has received numerous awards and its ambition is supported by prestigious investors. Wandercraft fulfills the promise of robotics to offer an Ordinary Life to Extraordinary People. www.wandercraft.eu.

Wandercraft将其外骨骼分发给医疗机构，并正在开发个人版本。它获得了众多奖项，其雄心壮志得到了知名投资者的支持。Wandercraft实现了机器人技术的承诺，为非凡的人提供平凡的生活。www.wandcraft.eu。

ABOUT CURE®Cure is a healthcare innovation campus in the heart of New York City that features cutting-edge wet and dry labs, office space, and premium event space—plus tools, mentoring, and other assistance to physician-scientists, entrepreneurs, academics, and nonprofits working across the spectrum of healthcare and biomedicine.

ABOUT CURE®CURE是一个位于纽约市中心的医疗创新园区，拥有先进的干湿实验室、办公空间和高级活动空间，以及为医生、科学家、企业家、学者和从事医疗保健和生物医学工作的非营利组织提供的工具、指导和其他帮助。

Cure's mission is to advance healthcare by accelerating the development of therapies and cures, and to facilitate critical conversations about the future of healthcare. For more information, please visit https://cure.345pas.com/..

Cure的使命是通过加速治疗和治愈的发展来推进医疗保健，并促进关于医疗保健未来的重要对话。有关更多信息，请访问https://cure.345pas.com/..

i Ding W, Hu S, Wang P, et al. Spinal Cord Injury: The Global Incidence, Prevalence, and Disability From the Global Burden of Disease Study 2019. Spine (Phila Pa 1976). 2022;47(21):1532-1540. doi:10.1097/BRS.0000000000004417.ii World Health Organization. Spinal Cord Injury. November 19, 2013. https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury#:~:text=There%20is%20no%20reliable%20estimate,injury%20appears%20to%20be%20growing.iii National Spinal Cord Injury Statistical Center, Traumatic Spinal Cord Injury Facts and Figures at a Glance.

丁伟，胡S，王平，等。脊髓损伤：2019年全球疾病负担研究的全球发病率，患病率和残疾。脊柱（Phila Pa 1976）。2022年；47（21）：1532-1540。doi:10.1097/BRS.0000000000004417.ii世界卫生组织。脊髓损伤。2013年11月19日。https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury#:~：text=There%20is%20no%20reliable%20estimate，injury%20appeated%20to%20be%20growing.iii国家脊髓损伤统计中心，创伤性脊髓损伤事实和数字一目了然。

2023. https://www.nscisc.uab.edu/public/Facts%20and%20Figures%202023%20-%20Final.pdf.iv U.S. Centers for Disease Control and Prevention. Stroke Facts. May 4, 2023. https://www.cdc.gov/stroke/facts.htm.v National Multiple Sclerosis Society. How Many People Live With MS? 2023. https://www.nationalmssociety.org/What-is-MS/Who-Gets-MS/How-Many-People..

2023https://www.nscisc.uab.edu/public/facts%20and%20figures%202023%20-%20Final.pdf.iv美国疾病控制和预防中心。中风事实。2023年5月4日。https://www.cdc.gov/stroke/facts.htm.v国家多发性硬化症学会。有多少人与MS住在一起？2023https://www.nationalmssociety.org/what-is-ms/who-gets-ms/how-many-people..

SOURCE Cure

源固化